PMID- 10759233 OWN - NLM STAT- MEDLINE DCOM- 20000420 LR - 20190721 IS - 0163-2116 (Print) IS - 0163-2116 (Linking) VI - 45 IP - 4 DP - 2000 Apr TI - Apolipoprotein E polymorphism in alagille syndrome and progressive familial intrahepatic cholestasis. PG - 675-9 AB - The aim of the study was to assess the apolipoprotein E polymorphism (apoE) in two familial cholestatic diseases-Alagille syndrome (AS) and progressive familial intrahepatic cholestasis (PFIC)-and to estimate its association with gallstone formation, cholesterol levels, and response to UDCA treatment. We investigated 16 children with AS age 8.8 +/- 5.7 years (mean +/- SD) and 18 children with PFIC age 6.3 +/- 4.6 years. The frequency of the epsilon-2 allele in AS and PFIC was higher and the frequency of the epsilon-3 allele was lower than in controls. Gallstones were diagnosed in nine children with PFIC and different apoE phenotypes. No association between phenotype and cholesterol levels or response to UDCA therapy was observed in the patients studied. In conclusion, the allele epsilon-2 is overrepresented in AS and PFIC, similar to primary biliary cirrhosis, although this does not seem to contribute to different cholesterol levels, gallstones, and response to UDCA therapy. FAU - Socha, P AU - Socha P AD - Children's Memorial Health Institute & National Institute of Food and Nutrition, Warsaw, Poland. FAU - Nowicka, G AU - Nowicka G FAU - Jankowska, I AU - Jankowska I FAU - Rujner, J AU - Rujner J FAU - Pawlowska, J AU - Pawlowska J FAU - Socha, J AU - Socha J LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Dig Dis Sci JT - Digestive diseases and sciences JID - 7902782 RN - 0 (Apolipoproteins E) RN - 0 (Cholagogues and Choleretics) RN - 724L30Y2QR (Ursodeoxycholic Acid) RN - 97C5T2UQ7J (Cholesterol) RN - RFM9X3LJ49 (Bilirubin) SB - IM MH - Adolescent MH - Alagille Syndrome/blood/drug therapy/*genetics MH - Apolipoproteins E/*genetics MH - Bilirubin/blood MH - Child MH - Child, Preschool MH - Cholagogues and Choleretics/*therapeutic use MH - Cholelithiasis/blood/*genetics/prevention & control MH - Cholestasis, Intrahepatic/blood/drug therapy/*genetics MH - Cholesterol/*blood MH - Female MH - Humans MH - Male MH - Phenotype MH - Polymorphism, Genetic MH - Pruritus/etiology MH - Retrospective Studies MH - Ursodeoxycholic Acid/*therapeutic use EDAT- 2000/04/12 09:00 MHDA- 2000/04/25 09:00 CRDT- 2000/04/12 09:00 PHST- 2000/04/12 09:00 [pubmed] PHST- 2000/04/25 09:00 [medline] PHST- 2000/04/12 09:00 [entrez] AID - 10.1023/a:1005475106198 [doi] PST - ppublish SO - Dig Dis Sci. 2000 Apr;45(4):675-9. doi: 10.1023/a:1005475106198.